How'd you fix Sentynl Therapeutics's revenue issues in 2026?
Direct Answer Sentynl's 2026 fix abandons the "single-indication rare-disease drug as cash-drain" positioning and locks three defensible revenue engines: (1) Outcome-locked NULIBRY-market-penetration-to-revenue contracts bundled with Chief …
Read full answer ↗